VivoSeq
Other

Skin

0

Pipeline Programs↗

18

Active Trials↗

24

Companies Involved↗

Skin is an early-stage landscape with 0 programs across 24 companies. The most active players are GSK, Bayer, Allergy Therapeutics.

Intelligence

Pipeline Metrics

Competitive Density

34/100

Pipeline Velocity

41/100

Mech. Concentration

N/A

Completion Rate

91/100

Attrition Rate

7/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

GSK logo

GSK

0 programs

PreclinicalBayer logo

Bayer

0 programs

PreclinicalA

Allergy Therapeutics

0 programs

PreclinicalAbbVie logo

AbbVie

0 programs

PreclinicalNovo Nordisk logo

Novo Nordisk

0 programs

PreclinicalS

Sofwave Medical LTD

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

109

clinical trials

Completed77 · 71%
Recruiting9 · 8%
Unknown status5 · 5%
Active, not recruiting5 · 5%
Not yet recruiting4 · 4%
Withdrawn4 · 4%
Other5 · 5%

Clinical Trials

Trial Activity

109 trials

Color Masking Potential of Bioactive and ICON Materials
Recruiting·KKing Abdullah University Hospital·N/A·NCT06402500·75 enrolled
Repurposing Dupilumab for Management of Pruritic Genetic Inflammatory Skin Disorders
Recruiting·NNorthwestern University·Phase 1·NCT05649098·30 enrolled
Feasibility Study for Fibroblast Autologous Skin Grafts
Recruiting·JJohns Hopkins University·Phase 2·NCT01964859·80 enrolled
Comparison of Objective Skin Barrier Function Parameters Between Women Who Use and Women Who Do Not Use UV Nail Lamps for Nail Treatments
Recruiting·UUniversity of Split, School of Medicine·N/A·NCT07700186·30 enrolled
Effect of Medical Adhesive and Skin Barrier Products Used for Central Venous Catheter Dressings on the Development of Medical Adhesive-Related Skin Injury: A Randomized Controlled Trial
Recruiting·—·Preclinical·NCT07697430·162 enrolled
A Clinical Study to Evaluate the Safety and Tolerability of Intradermal Delivery of CFH Protein Via Ice Microneedles for the Prevention of Radiation-Induced Skin Fibrosis
Recruiting·WWest China Hospital·Phase 1·NCT07567235·9 enrolled
Post-Market Interventional Clinical Investigation to Evaluate the Safety and Efficacy of RRS® HA Long Lasting for the Improvement of Facial Wrinkles and Skin Quality
Recruiting·SSkin Tech Pharma Group S.L.U.·Preclinical·NCT07551609·207 enrolled
Assessment of the Effect of Helichrysum Italicum Extract in Irritant Contact Dermatitis: A Randomized Controlled Clinical Trial
Recruiting·UUniversity of Split, School of Medicine·Preclinical·NCT07676253·30 enrolled
Assessment of Skin Manifestations Occuring During Covid-19 Infection With a Special Focus on Chilbains
Recruiting·CCentre Hospitalier Universitaire de Nice·N/A·NCT04344119·30 enrolled
A Study to Find Out How Litifilimab is Processed in the Body in Healthy Participants When Given Under the Skin in 3 Different Ways
Active, not recruiting·Biogen logoBiogen·Phase 1·NCT06741657·404 enrolled
Pilot Observational Evaluation of Facial and Neck Skin Laxity With SofWave Treatment in Adults Initiating Tirzepatide for Weight Loss
Active, not recruiting·SSofwave Medical LTD·Preclinical·NCT07685834·30 enrolled
In Vivo Study to Evaluate Tissue Remodeling Via Fibroblast Stimulation Following a Single SofWave Treatment
Active, not recruiting·SSofwave Medical LTD·Preclinical·NCT07685821·10 enrolled
Optimization of Low-Level Laser Therapy Via Biomechanical Properties Analysis Using Optical Coherence Tomography on Skin
Active, not recruiting·Asia University·Preclinical·NCT07680309·20 enrolled
A Pilot Study of Skin Elasticity Measurements of the Face and Surgical Scars Stratified by Age and Skin Type
Active, not recruiting·NNorthwestern University·N/A·NCT01688063·35 enrolled
Characterization of Skin and Facial Fat Pad Thickness Changes Following Microneedling Radiofrequency With and Without Topical Poly-L-Lactic Acid for Facial Rejuvenation
Not yet recruiting·TThe University of Texas Health Science Center, Houston·N/A·NCT07261527·30 enrolled
Page 1 of 8

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)